New treatment option for Atrial Fibrillation (Paroxysmal)
Official title Biofeedback Intervention for Paroxysmal Atrial Fibrillation
ClinicalTrials.gov ID: NCT07454317
What this study is testing
- What it's testing
- This project aims to bridge the gap between technology and healthcare by developing a biofeedback intervention that enables daily monitoring of atrial fibrillation episodes and physical activity levels. The main question it aims to answer is: Is a co-designed, usability-tested, bio-feedback intervention aimed at nudging patients with paroxysmal atrial fibrillation to increase physical activity feasible for a larger randomised control trial?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participant is willing and able to give informed consent for participation in the study.
- Aged 18 or over.
- Diagnosed with paroxysmal AF
- Deemed medically stable and well managed.
You likely can't join if
- Any concurrent cardiac arrhythmia
- Blood pressure \>180/100
- Unstable angina
- Myocardial infarction within the previous 3 months
- Valvular heart disease
- Heart failure NYHA class 4
See the full eligibility criteria
- Participant is willing and able to give informed consent for participation in the study.
- Aged 18 or over.
- Diagnosed with paroxysmal AF
- Deemed medically stable and well managed.
- Any concurrent cardiac arrhythmia
- Blood pressure \>180/100
- Unstable angina
- Myocardial infarction within the previous 3 months
- Valvular heart disease
- Heart failure NYHA class 4
- \<6 months post-transplant
- Resting/uncontrolled tachycardia
- Stroke in last 6 weeks
- Cardiac sarcoidosis
- Injury or disability preventing exercise
The study team makes the final eligibility decision.
Where it's taking place
- Liverpool, Merseyside, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Liverpool, Merseyside, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.